A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Key Points

• This resolution states that the Senate believes mifepristone is a safe and effective medication. It points to 25 years of medical data and hundreds of studies showing the drug has very few risks.
• The proposal argues that the FDA should have the final say on drug safety. It says that judges or politicians should not interfere with scientific decisions about which medicines Americans can use.
• It highlights that medication abortion made up 63 percent of all abortions in 2023. The resolution supports keeping the drug available through the mail and telehealth to help people who live far from a doctor.
• The resolution specifically mentions that blocking this medicine hurts certain groups more than others. This includes people with low incomes, those living in rural areas, and people of color who already face hurdles in getting healthcare.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.